|
|
What Interests You? |
The page you were looking for no longer exists. The following search results may be of interest.
|
Provenge FDA Approval Granted for Prostate Cancer Treatment
Article
Dendron Corporation's drug, Provenge, received FDA approval as a prostate cancer therapy on April 29, 2010.
May 1, 2010
-
Cheri Pearson
|
|
Masitinib Drug Approved for Therapy of Mast Cell Tumors in Dogs
Article
A new cancer drug called Kinavet-CA1 (masitinib) has been granted conditional approval by the U.S. FDA for use by vets to treat dogs with mast cell tumors.
Jan 31, 2011
-
Amy Haase
|
|
FDA Panel Approves First Oral MS Treatment
Article
Gilenia could be the first drug approved in the U.S. to treat relapsing-remitting multiple sclerosis that is not injected or infused. It's a pill.
Sep 10, 2010
-
Fran Gardner
|
|
FDA Approves Gilenya (fingolimod), a Pill for MS
Article
The FDA has approved the first U.S. MS pill. Gilenya, also known as fingolimod, is aimed at patients with relapsing-remitting multiple sclerosis.
Sep 22, 2010
-
Fran Gardner
|
|
FDA Reports Record Number of Drug Shortages in 2010
Article
The Food and Drug Administration reported 178 drug shortages in 2010, a record that has persisted into 2011. Some of your medications could be on the list.
Sep 7, 2011
-
Stephen Allen Christensen
|
|
Bariatric Physicians Question FDA for Not Approving New Diet Drug
Article
Weight loss physicians are saying that the FDA seems to be holding bariatric drugs to a higher standard than drugs used primarily for other conditions.
Feb 20, 2011
-
Raechelle Janzen
|
|
Palladia - A New Cancer Treatment for Dogs
Article
Palladia is a newly introduced drug which is used as a treatment option for cutaneous mast cell tumors. Palladia may be used with other therapies to treat this cancer.
Jun 3, 2009
-
Lorie Huston
|
|
FDA Approves New 3-D Mammography Imaging System
Article
A new mammography system that uses 3-D technology will help in diagnosing breast cancer more accurately in women.
Feb 13, 2011
-
Raechelle Janzen
|
|
Weight-loss Drug Lorcaserin Fails to Get FDA Approval
Article
It's been a decade since the U.S. Food and Drug Administration green lit a new prescription weight-loss pill. The latest to be turned down may be back.
Oct 25, 2010
-
Marcus Hondro
|
|
FDA Approved Prescription Weight Loss Drugs and OTC Diet Pills
Article
FDA approved prescription weight loss drugs include appetite suppressants & orlistat, a lipase inhibitor that is also the only approved OTC diet pill around
May 20, 2010
-
Christine Redmond
|
|
FDA-approved Weight Loss Drug - Panel Suggests Meridia Withdrawal
Article
FDA-approved weight loss drug Meridia/sibutramine may be withdrawn from market or have use restricted following advisory panel safety concerns of diet pill
Sep 17, 2010
-
Christine Redmond
|
|
FDA Approves New Antivenom for Bark Scorpion Stings
Article
Scorpion stings can be not only painful, but life-threatening. Now there is an antivenom that can help allay the reactions.
Oct 25, 2011
-
Rosemary King
|
|
FDA Approves LAP-BAND® System for Patients Who are Less Obese
Article
The FDA has approved Lap Band surgery for some patients who before now might not have met criteria for it. They have lowered the BMI requirements.
Feb 17, 2011
-
Raechelle Janzen
|
|
Dogs Help Human Cancer Research
Article
6 million dogs are diagnosed with cancer each year, but thanks to new techniques, their struggles may shed new light on the disease.
Sep 24, 2009
-
Kathleen Hesketh
|
|
FDA Approves Botox Injections for Chronic Migraine Headaches
Article
On October 15, 2010, the United States Food and Drug Administration approved the use of Botox for the treatment of chronic migraine headaches in adults.
Oct 15, 2010
-
Renee Guzman-Simon
|
|
Estimating Drug Probabilities of Success in FDA Clinical Trials
Article
This article will help investors in biotech and pharmaceutical companies to predict the probability of success of drugs in clinical trials.
Jul 9, 2010
-
Lee Samaha
|
|
FDA approves New Test to Help Kidney Transplant Patients
Article
A new blood test to monitor the blood level of the anti-rejection drug everolimus, which is marketed under the name of Zortess.
Feb 12, 2011
-
Raechelle Janzen
|
|
Prostate Cancer Drug Zytiga Extends Life; UK, Europe to Approve
Article
In clinical trials Zytiga has shown to extend the lives of aggressive prostate cancer patients on average by four months. Its use in Europe is near.
Jul 23, 2011
-
Marcus Hondro
|
|
New and Generic Drug Approvals for September 6, 2011
Article
Five new labeling revisions and one new drug were approved on Sept. 6, 2011 by the FDA.
Sep 7, 2011
-
Tina Samuels
|
|
New Injectable Drug Prolia Approved for Osteoporosis Treatment
Article
Prolia, an injectable drug to treat osteoporosis in postmenopausal women, was approved June 1, 2010, by the United States Food and Drug Administration.
Jun 7, 2010
-
Rebecca Johnston
|